Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Fra2/LCN2 Links PM2.5 to Asthma Ferroptosis
2026-08-31
A 2026 Redox Biology study identifies Fra2-driven LCN2 activation as a mechanistic link between PM2.5 exposure, impaired mitophagy, and ferroptosis in M2 macrophages during asthma aggravation. Genetic LCN2 suppression reduced airway inflammation and improved lung function in mice, providing a framework for studying pollution-associated asthma through macrophage iron and redox biology.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-31
FITC-Concanavalin A is a fluorescent lectin conjugate for visualizing α-D-glucose and α-D-mannose residues associated with glycoproteins and glycolipids. It is appropriate for cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but it should not be used as a universal glycan stain or as a probe for non-carbohydrate targets.
-
Kitasamycin for Swine Dysentery: Evidence and Limits
2026-08-30
This study tested kitasamycin against Australian Brachyspira hyodysenteriae isolates and in experimentally infected pigs, linking isolate-level susceptibility with prevention and treatment outcomes. Its central practical finding is that kitasamycin controlled swine dysentery caused by a susceptible isolate, while widespread macrolide resistance limits broad therapeutic generalization.
-
Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor
2026-08-29
Z-LEHD-FMK is an irreversible caspase-9 inhibitor for dissecting mitochondria-mediated apoptosis. Its reported use spans apoptosis assays, TRAIL-rescue experiments, cancer research, and preclinical neuroprotection workflows.
-
Alternariol (AOH) Workflow for Fibrosis Research
2026-08-28
Build a controlled AOH workflow that connects chemical exposure to LX-2 activation, apoptosis, cytochrome P450 biology, and detoxification testing. This practical guide separates literature-supported mechanisms from starting conditions for dose finding, phenotype validation, and troubleshooting.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-28
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for examining TLR7/9 signaling and autophagy pathway modulation in autoimmune disease research. It is suited to short-term, water-based cellular or animal workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
SB-3CT: Selective Gelatinase Inhibitor
2026-08-27
SB-3CT is a mechanism-based gelatinase inhibitor that preferentially targets MMP-2 and also inhibits MMP-9. Its preclinical profile supports tumor metastasis research, extracellular-matrix studies, and neuroprotection in cerebral ischemia, while assay-specific potency and limited translational evidence require careful interpretation.
-
Coelenterazine Workflows for ROS Assays
2026-08-27
Coelenterazine links luciferase-compatible reporting with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide shows how to adapt it for AVP reporter studies, BRET, oxidative stress measurement, high-throughput screening, and cancer-associated reactive oxygen species imaging while controlling solvent and signal confounders.
-
Cucurbitacin I (JSI-124): STAT3 Research Guide
2026-08-26
Cucurbitacin I, also called JSI-124, is a research inhibitor of JAK2/STAT3 signaling with reported activity in cancer cell and xenograft models. This guide summarizes its mechanism, benchmark conditions, formulation limits, and assay applications without treating vendor-reported findings as universal biological constants.
-
DiscoveryProbe FDA-approved Drug Library for HTS
2026-08-26
The DiscoveryProbe FDA-approved Drug Library converts a clinically informed compound set into a practical workflow for phenotypic screening, protein-folding rescue, and drug repositioning screening. Its 2,320 pre-dissolved compounds support rapid hit discovery while secondary assays distinguish genuine pharmacology from fluorescence, viability, and proteostasis artifacts.
-
Senescent CAFs Suppress NK Immunity in Breast Cancer
2026-08-25
Ye et al. identify senescent myofibroblast cancer-associated fibroblasts as a distinct, tumor-promoting stromal population that suppresses natural killer cell cytotoxicity through extracellular matrix remodeling. The study connects genetic or pharmacologic senCAF elimination with restored antitumor immunity and shows that senCAFs occur across major breast cancer subtypes and in ductal carcinoma in situ.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-25
FITC-Concanavalin A (ConA) Conjugate provides fluorescence-based detection of α-D-glucose and α-D-mannose moieties on cell surfaces and tissue sections. It is suited to immunofluorescence staining, microscopy, and flow cytometry carbohydrate workflows, but should not be used as a general probe for non-glycan targets or outside the specified storage conditions.
-
Baicalein Workflows for 12-LOX Research
2026-08-24
Build reproducible Baicalein experiments around 12-LOX inhibition, apoptosis, inflammation, and cancer-cell selectivity. This practical guide combines solvent handling, dose-response design, orthogonal validation, and a reference-study-inspired workflow for separating pathway activity from nonspecific cytotoxicity.
-
HLY78: Ligand-Dependent Wnt Signaling Workflows
2026-08-24
HLY78 is a Wnt/β-catenin pathway modulator for testing ligand-dependent signaling through the Axin–LRP6 interface. This guide translates its mechanism into practical workflows for zebrafish embryogenesis, hematopoietic marker induction, and mechanistic fibrosis studies while emphasizing controls and troubleshooting.
-
BAPTA-AM: Practical Calcium Chelation Workflows
2026-08-23
BAPTA-AM is a cell-permeable calcium chelator for testing how intracellular Ca²⁺ contributes to signaling, apoptosis, ion-channel activity, and injury responses. It is useful for controlled cellular assays when loading, vehicle effects, magnesium interference, and potassium-channel blockade are measured in parallel; it should not be interpreted as a calcium-only reagent without these controls.